{
    "2019-06-17": [
        [
            {
                "time": "",
                "original_text": "“青蒿素抗药性”研究获突破刺激医药板块拉升，券商建议配置三类股",
                "features": {
                    "keywords": [
                        "青蒿素",
                        "抗药性",
                        "研究突破",
                        "医药板块",
                        "券商建议",
                        "三类股"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业跨市场周报:“大医保”时代下再平衡,拥抱确定性",
                "features": {
                    "keywords": [
                        "医药生物",
                        "跨市场",
                        "大医保",
                        "再平衡",
                        "确定性"
                    ],
                    "sentiment_score": 0.65,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}